Developer of molecular imprinted polymers (MIPS) and nanoMIPs/plastic antibodies technology designed to circumvent the drawbacks of traditional MIP manufacturing methods. The company's molecular imprinted polymers (MIPS) and nanoMIPs/plastic antibodies typically contain a single binding site for their target and are sufficiently small to be essentially soluble and can be fused to solid substrates, such as sensor surfaces, providing enterprises with ideal reagents for a wide range of applications including point-of-care diagnostics and in field based testing.